Surprise! 10 robotics companies are on the road to IPO

2023 seems to be a good time to go public. After the epidemic was fully lifted, the theme of all industries was recovery, and robots were no exception. The development momentum became stronger. Under the favorable trend of the industry, some machine companies turned their attention to IPOs.

In addition to the special support of the latest policies, the introduction of new listing rules of the Hong Kong Stock Exchange and the comprehensive registration system for A-shares, these are all favorable factors for the innovative technology industry represented by robots, making listing easier.

In a recent survey, Weike.com Robotics found that at least ten robot companies are on the road to IPO, including Jieka, Yuejiang, Aobo, Giant Robotics, Jingfeng Medical , Shurui, Jianjia Robotics, UBTECH Robotics, Hikvision Robotics, Dahua, etc., covering collaborative robots , industrial robots , surgical robots, humanoid robots, mobile robots, intelligent robots and other subcategories.

Jieka Robot

On December 19, 2022, Jieka Robotics signed a listing guidance agreement with Guotai Junan Securities Co., Ltd. to start the IPO process.

According to the information, JEKA Robotics was founded in 2014 and is committed to innovating the way people interact with robots. JEKA Robotics has been deeply integrating emerging technologies such as artificial intelligence and big data, and has been developing towards multi-dimensional intelligent development, that is, upgrading from single perception to global perception, from perceptual intelligence to cognitive intelligence, and from stand-alone intelligence to cluster intelligence, pushing collaborative robots towards a more flexible and intelligent era.

JIEKA Robotics has realized nine core technologies, six core algorithms, and six series of collaborative robot product matrices. Currently, it has deployed more than 10,000 robots worldwide. Its products flexibly and efficiently serve the production lines of global renowned brands such as automobiles, electronics, and semiconductors. At the same time, it is also engaged in service work that directly contacts consumers in many new commercial consumer fields.

In July last year, Jieka Robot announced the completion of a Series D financing of approximately RMB 1 billion, led by Temasek, SoftBank Vision Fund II and other institutions. As a result, Jieka Robot has completed six rounds of financing, totaling more than RMB 1.4 billion, making it the company with the most financing rounds and the largest financing scale in the field of collaborative robots.

Yuejiang Technology

On January 19, 2023, Yuejiang’s listing guidance filing was accepted by the China Securities Regulatory Commission. The guidance institution is CICC, and the listing guidance process is expected to be completed in April or May.

Founded in 2015, Yuejiang Technology is a world-leading intelligent collaborative robot company headquartered in Shenzhen, with branches and subsidiaries in Shanghai, Suzhou, Hangzhou, Chengdu, Qingdao, Rizhao, Dallas, USA, Frankfurt, Germany and Tokyo, Japan. It has three major business groups: domestic industry, domestic education and overseas, and has deeply deployed in the global market.

After years of development, Yuejing Technology now has 7 series and more than ten products, becoming the first collaborative robot company in the industry with a full product matrix of 0.5-16kg. Its application areas cover 15 major industries such as automobiles, 3C, and semiconductors. Its products are exported to more than 140 countries and regions around the world. As of 2022, the cumulative sales volume has reached 68,000 units, ranking No. 1 in the export volume of domestic industrial robots for consecutive years.

At present, Yuejiang Technology has completed 5 rounds of financing and has successively obtained investments from many well-known institutions such as Daosheng Capital, Entertainment Factory, Shenzhen Capital Group, Qianhai Mother Fund, CICC Capital, CRRC Capital, Wen's Capital, China Merchants Capital, Yunhui Capital, and Potential Capital. In November 2022, after Yuejiang Technology completed its D round of financing, it completed strategic financing again on December 23.

Aobo Intelligent

It is understood that Aubo Intelligent plans to be listed on the Science and Technology Innovation Board in the third quarter of this year, and its listing guidance agency is Huatai United Securities.

Founded in 2015, AUO Robotics has been deeply engaged in the field of collaborative robots for a long time, breaking through many key software and hardware technologies of collaborative robots, conquering robot operating systems, integrated joints, servo control, joint torque sensors , application software development environment and other core technologies of robots, breaking the foreign monopoly and realizing the localization of core components. In 2022, it became the first and currently the only collaborative robot company to win the national "Manufacturing Single Champion".

In response to the differentiated applications in various industries, AUO Robotics has developed a number of product series, such as the i series collaborative robots for industrial applications, the C series collaborative robots for commercial service applications, the E series collaborative robots for education applications, and mobile collaborative robots.

At present, Aubo Intelligent's products have been widely used in many fields such as 3C electronics, auto parts, education, new retail, medicine and healthcare, and have gradually penetrated from the industrial field to diversified non-industrial fields. It is the first company to introduce collaborative robots into the field of big health and the first company to launch explosion-proof collaborative robots in the petrochemical industry. In recent years, the sales share in the non-industrial field has reached more than four times the total sales.

Giant Robot

Recently, Juneng Robotics' application for listing on the Beijing Stock Exchange has been submitted for registration, and it has responded to the opinions raised at the Listing Committee meeting.

Public information shows that Juneng Co., Ltd. is a supplier of overall intelligent manufacturing solutions with robots and related intelligent technologies as the core. The company's main products are used in equipment manufacturing fields such as automotive parts, construction machinery, aerospace, military industry, rail transit, elevators and other general machinery.

This time, Juneng Robot plans to raise 211 million yuan, of which 128 million yuan will be used for the industrial robot and intelligent equipment production base project, 34 million yuan will be used for the R&D center construction project, and 50 million yuan will be used to supplement working capital.

In terms of financial data, from 2019 to 2021, Juneng Robot achieved revenue of 138 million yuan, 152 million yuan, and 209 million yuan, respectively, with year-on-year growth rates of 84.67%, 10.50% and 37.42%, respectively; the net profit attributable to the parent in the same period was 9.9287 million yuan, 30.1570 million yuan and 30.1571 million yuan, respectively, with year-on-year growth rates of 500.42%, 203.73% and 0%, respectively.

In 2022, Juneng Co., Ltd. achieved operating income of 274 million yuan, an increase of 31.14% over the same period in 2021; net profit attributable to shareholders of the parent was 36.5999 million yuan, an increase of 21.36% over the same period in 2021; net cash flow generated from operating activities was 20.9150 million yuan, a decrease of 50.74% over the same period in 2021, mainly due to the impact of the new crown pneumonia epidemic, which delayed the repayment time of some customers.

It is worth noting that Juneng shares seem to be facing huge debt repayment pressure. From 2019 to 2021 and the first half of 2022, Juneng Robot's debt-to-asset ratio was 79.45%, 76.40%, 71.56% and 61.34% respectively.

Juneng shares said that the company's high asset-liability ratio is mainly due to the large demand for working capital in the industry in which the company is located. If the company's operating performance in the future does not meet expectations or even declines, resulting in a decrease in operating cash inflow, or it is difficult to raise debt repayment funds through external financing, it will put certain pressure on the company's capital chain, thus having an adverse impact on the company's daily operations.

Elite Medical

Earlier this year, Elite Medical submitted a second application for listing on the Hong Kong Stock Exchange's main board, with Morgan Stanley, CICC and Citi as joint sponsors. It had previously submitted a listing application to the Hong Kong Stock Exchange on April 19, 2022, but the information is now invalid.

According to information, Jingfeng Medical was founded in 2017 and is an advanced surgical robot company in the medical device industry. It has four major product pipelines centered on robotic technology: multi-port laparoscopic surgical robot system, single-port laparoscopic surgical robot system, natural orifice surgical robots, and traditional minimally invasive surgical instruments.

In December 2022, the MP1000 multi-hole laparoscopic surgical robot of Precision Medical was approved for marketing by the National Medical Products Administration in the field of urology. It is applicable to gynecology, general surgery and other fields, and relevant clinical trials are underway.

In terms of financial data, Precision Medical had zero revenue in 2021 and the first three quarters of 2022, with losses of 349 million yuan and 147 million yuan during the period, mainly due to R&D expenses. The company stated that its business and financial prospects depend to a large extent on the success of its products under development. If the company fails to successfully complete clinical trials, obtain regulatory approval and commercialize its products under development, or experiences significant delays in such processes, the company's prospects may be significantly adversely affected.